Reporting
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreCompleted
Reporting
The development and validation of a patient-reported measure of antiretroviral therapy’s interference with life: a clinical patient-management tool for healthcare providers
Learn MoreOngoing
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Learn MoreCompleted
Prospective investigation of the relationship between food insecurity and health and behavioural outcomes in HIV-HCV co-Infection: Clues for prevention interventions. A food security & HIV-HCV sub-study of the Canadian Co-Infection Cohort (CTN 222)
Learn MoreReporting
Canadian HIV women’s sexual and reproductive health cohort study
Learn MoreCompleted
A randomized, double blind, phase IIB study testing the efficacy and safety of AGS-004 on host control of HIV replication during analytical treatment interruption: Trial results
Learn MoreReporting
Predictive value of inflammatory biomarkers in untreated HIV disease progression, and their response to initiation of antiretroviral therapy
Learn MoreReporting
A study of host and viral factors associated with disease progression in long term HIV infected subjects
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
